News

Vaxxinova wins Animal Pharm Award for Best European Company 2018

Nijmegen, The Netherlands, 18 January 2019 Vaxxinova is honored to receive the Animal Pharm Award for Best European Company 2018. We are pleased to see that the importance of disease prevention and the role that vaccines play in this, is recognized. As Animal Pharm indicates, “The judging panel for the awards liked the acquisitions Vaxxinova made […]
Read more →

Vaxxinova acquires Epitopix

PRESS RELEASE WILLMAR, MINNESOTA February 22, 2018 Vaxxinova acquires Epitopix Vaxxinova, an EW-group company with core business focusing on animal health, has concluded an agreement to acquire 100% of the shares in Epitopix, a US based animal health company specialized in poultry and livestock biologicals and founder of SRP® technology. The transaction will be concluded by […]
Read more →

Vaxxinova, headquartered in The Netherlands, acquires Laboratório Biovet

PRESS RELEASE VARGEM GRANDE PAULISTA, SAO PAULO, February 1, 2018. Vaxxinova, a subsidiary of the EW Group, has acquired Laboratório Biovet, a Brazilian company with 60 years of commitment to the animal health industry. Biovet was founded in 1957 by veterinarian René Corrêa, and has remained a family-owned company since then. The company is strongly […]
Read more →

Vaxxinova is expanding its regional support

NIJMEGEN, 16 January 2018 We are very proud to announce that we are completing the set-up of a new diagnostic lab in Amman, Jordan together with a new Representative Office to support the Middle East area and African area where applicable with full-fledged poultry diagnostic services. With this lab, we will be able to deliver […]
Read more →